Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with Temozolomide

Clinical trial NCT00102648 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT00102648

Sponsor

M.D. Anderson Cancer Center

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2004-12-21

Primary completion

2025-03-01

Enrollment

34

View on ClinicalTrials.gov